Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Isoxazolo[3,4-b]pyridin-3-amine, 4,6-dimethyl(9CI) is a heterocyclic amine with the molecular formula C9H10N3O. It features an isoxazole ring fused to a pyridine ring, along with two methyl groups at the 4 and 6 positions. This chemical compound is a potential drug candidate that has been studied for its pharmacological properties, particularly for its potential therapeutic applications in treating various diseases.

670246-33-0

Post Buying Request

670246-33-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

670246-33-0 Usage

Uses

Used in Medicinal Chemistry:
Isoxazolo[3,4-b]pyridin-3-amine, 4,6-dimethyl(9CI) is used as a potential therapeutic agent in the field of medicinal chemistry for its pharmacological properties. It is being studied for its potential to treat various diseases, making it a valuable compound in drug discovery and development.
Used in Drug Discovery:
In the realm of drug discovery, Isoxazolo[3,4-b]pyridin-3-amine, 4,6-dimethyl(9CI) serves as a promising candidate for further research and development. Its unique structure and potential pharmacological activities warrant investigation into its biological and chemical properties to fully understand its therapeutic potential.
Further research is necessary to explore the specific applications and optimize the use of Isoxazolo[3,4-b]pyridin-3-amine, 4,6-dimethyl(9CI) in various industries, particularly in the pharmaceutical sector.

Check Digit Verification of cas no

The CAS Registry Mumber 670246-33-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,0,2,4 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 670246-33:
(8*6)+(7*7)+(6*0)+(5*2)+(4*4)+(3*6)+(2*3)+(1*3)=150
150 % 10 = 0
So 670246-33-0 is a valid CAS Registry Number.

670246-33-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,6-dimethyl-[1,2]oxazolo[3,4-b]pyridin-3-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:670246-33-0 SDS

670246-33-0Downstream Products

670246-33-0Relevant articles and documents

Pharmacophore modeling, 3D-QSAR, synthesis, and anti-lung cancer evaluation of novel thieno[2,3-d][1,2,3]triazines targeting EGFR

Abdel Aziz, Yasmine M.,Elewa, Marwa,Elgawish, Mohamed S.,Elrayess, Ranza,Elshihawy, Hosam A.,Said, Mohamed M.

, (2020/01/24)

Two series of thieno[2,3-d][1,2,3]triazine derivatives were designed, synthesized, and biologically evaluated as potential epidermal growth factor receptor (EGFR) inhibitors targeting the non-small-cell lung cancer cell line H1299. Most of the synthesized compounds displayed IC50 values ranging from 25 to 58 nM against H1299, which are superior to that of gefitinib (40 μM). 3-(5,6,7,8-Tetrahydro-7H-cyclohexa[4:5]thieno[2,3-d]-1,2,3-triazin-4-ylamino)benzene-1,3-diamine (6b) achieved the highest cytotoxic activity against H1299 with an IC50 value of 25 nM; it had the ability to decrease the EGFR concentration in H1299 cells from 7.22 to 2.67 pg/ml. In vitro, the IC50 value of compound 6b was 0.33 nM against EGFR, which is superior to that of gefitinib at 1.9 nM and erlotinib at 4 nM. The three-dimensional quantitative structure–activity relationships and molecular modeling studies revealed comparable binding modes of compound 6b, gefitinib, and erlotinib in the EGFR active site. The in silico ADME (absorption, distribution, metabolism, and excretion) prediction parameters of this compound revealed promising pharmacokinetic and physicochemical properties. Moreover, DFT (density functional theory) calculations showed the high reactivity of compound 6b toward the EGFR compared with other compounds. The designed compound 6b might serve as an encouraging lead compound for the discovery of promising anti-lung cancer agents targeting EGFR.

Synthesis, reactions and biological activity of 2-substituted 3-cyano-4,6-dimethylpyridine derivatives

Yassin

experimental part, p. 35 - 41 (2009/06/28)

The reaction of 2-chloro-4,6-dimethylpyridine-3-carbonitrile with hydrazine hydrate, hydroxylamine, and anthranilic acid afforded the corresponding pyrazolo, isoxazolo, and pyridoquinazoline derivatives. Alkylation of 2-mercapto-4,6-dimethylpyridine-3-carbonitrile with ethyl chloroacetate or phenacyl bromide followed by cyclization in NaOH gave thienopyridine derivatives. Diazotization of ethyl 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2- carboxylate followed by the reaction with thiourea, guanidine carbonate, and hydroxylamine hydrochloride gave the corresponding thienopyridine derivatives. The biological activity of some new compounds has been discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 670246-33-0